InfuSystem Holdings, Inc. (NYSE American: INFU) has named Beverly A. Huss as its new board chair. The appointment follows the company’s annual shareholders’ meeting on May 1, 2026.
SEC filings confirm no related-party transactions exist between Huss, the CEO, or other individuals tied to the role. Huss fully complies with Regulation S-K Item 404(a) requirements, maintaining appropriate internal controls without significant related relationships. The company, headquartered in Rochester Hills, Michigan, holds a seller note asset in Delaware originally from Roche.
Q1 2026 Earnings Surpass EPS Expectations
InfuSystem reported first-quarter 2026 earnings per share (EPS) of $0.05, beating analyst forecasts of $0.03 by 66.67%. Revenue reached $33.7 million, however, falling short of the $34.56 million projection by 2.49%.
Shareholders Elect Seven Directors
At the annual meeting, investors approved seven board members: Kenneth D. Eichenbaum, Paul A. Gendron, Ronald Hundzinski, Beverly A. Huss, Carrie Lachance, Scott Shuda, and John J. Sviokla. These elections appear in the official shareholder notice.
